According to this data, XIAP is thought to render tumour cells resistant to multi-agent chemotherapy through its ability to inhibit caspases, and, on this basis, has been proposed as an important adverse prognostic factor responsible for tumour chemoresistance (Schimmer et al, 2006). The gene discussed is XIAP; the disease is neoplasm.